Compare Cardinal Health Inc (CAH) vs YieldMax NVDA Option Income Strategy ETF (NVDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs YieldMax NVDA Option Income Strategy ETF — how do they compare? Cardinal Health Inc trades at $228.8 (market cap $53.89B), while YieldMax NVDA Option Income Strategy ETF trades at $12.8. The key difference: Cardinal Health Inc pays a 0.89% dividend while YieldMax NVDA Option Income Strategy ETF pays none, and Cardinal Health Inc is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| CAH | NVDY | |
|---|---|---|
Market Cap | $53.89B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $239.71 | $17.96 |
52-Week Low | $146.04 | $12.03 |
Enterprise Value | $58.87B | — |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
NVDY, the YieldMax NVDA Option Income Strategy ETF, trades at $12.43, down 2.51% today, reflecting bearish technical signals with moving averages indicating selling pressure. The fund generates weekly dividends but lacks traditional valuation metrics like P/E or P/S, as it is structured to monetize NVIDIA's volatility through options strategies. Recent news highlights its focus on income generation at the potential cost of capping NVIDIA's upside returns.
The outlook for NVDY hinges on sustained options premium income amid NVIDIA's stock volatility, offering high distribution yields but limiting capital appreciation. Key risks include underperformance versus holding NVIDIA directly, fee drag, and dependency on market conditions for options profitability. Investors seeking income may find value, but growth-oriented investors face significant opportunity cost.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →
